Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2020

Aug 5, 2020

29841_dirs_2020-08-05_f9b4e385-d4c8-477d-ba34-01cfbc9b2cab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-08-03

Reporting Person: Surface Carol A (SVP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-03 Ordinary Shares A 4727 Acquired 49040 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-03 Stock Option (Right to Buy) $97.33 A 43451 Acquired 2030-08-03 Ordinary Shares (43451) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 1575 Acquired 2030-08-03 Ordinary Shares (1575) Direct
2020-08-03 Stock Option (Right to Buy) $97.33 A 34005 Acquired 2030-08-03 Ordinary Shares (34005) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 559 Indirect

Footnotes

F1: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date.

F2: Between June 1, 2020 and July 31, 2020, the reporting person acquired 4 shares of MDT common stock under the Medtronic NQ Retirement Plan. The information in this report is based on a statement dated as of July 31, 2020.

F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.